EL.PA ESSILORLUXOTTICA
Healthcare · Medical Instruments & Supplies
154.40
+3.83%
About the company
EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, sunglasses, and instruments and equipment in North America, the Middle East, Africa, Europe, Latin America, and the Asia-Pacific. It offers lens, eyewear, contact lenses, reading glasses under Essilor, Varilux, Crizal, Eyezen, Stellest, Xperio, Transitions, Ray-Ban, Oakley, Barberini, KODAK Lens, Nikon, Shamir Optical, eyexpert, iWear, Humanware, Optifog, Persol, Oliver Peoples, Vogue Eyewear, Arnette, Alain Mikli, Costa, Bliz, Native Eyewear and Bolon, and Foster Grant brands. The company also provides vision assessment, eye pathology diagnosis and treatment, finishing equipment, fitting parameter measurement, small tools, and consumables. In addition, it offers SPECTRALIS, a multimodal imaging platform for diagnosis and treatment; RetinAI; Espansione Group; Cellview Imaging; ANTERION, a multidisciplinary all-in-one anterior segment imaging solution for measurements; apparel, footwear and accessories; and high-tech equipment for optical surfacing, polishing, measuring, coating, and finishing, as well as consumables, tools, and services under the Satisloh brand. Further, the company designs, develops, markets, and maintains diagnostics, refraction, lens edging and mounting instruments for opticians and prescription laboratories, and measurement; and optometry instruments for eyecare professionals, schools, occupational medicine centers, military, and other institutions. It sells its products to independent opticians, distributors, third-party e-commerce platforms, and large retail chains in the eyecare and eyewear industry; and consumers through the network of brick and mortar retail networks and its online channels. The company was formerly known as Essilor International Société Anonyme and changed its name to EssilorLuxottica Société anonyme in October 2018. EssilorLuxottica Société anonyme was founded in 1849 and is headquartered in Paris, France.
52-week range
Dividend deep dive
ESSILORLUXOTTICA (EL.PA) operates within the Medical Instruments & Supplies industry. The company's current dividend yield is 2.59% based on a market price of 154.4 EUR. This yield is above its 5-year high of 1.9%, which Yield Theory indicates as an "undervalued" status. Specific momentum, value, and overall rating scores are not available in the provided data. The company has a market capitalization of 70,772,686,848.0 EUR.
Dividend history
The company currently has a dividend streak of 0 years, with annual payments typically occurring in May. ESSILORLUXOTTICA has shown strong dividend growth with a 3-year dividend CAGR of 16.32% and a 5-year dividend CAGR of 27.99%. Annual dividends per share have progressed from 0.94 EUR in 2014 to 3.23 EUR in 2023. The dividend for 2024 and 2025 is projected at 3.95 EUR, indicating a flat dividend for these two years following previous increases.
Dividend safety
The dividend payout ratio stands at 74.77% of earnings, indicating a significant portion of earnings is used for dividend distribution. The company's debt-to-equity ratio is 38.36%.
Quantic · Free
Read the rest of the safety verdict
Plus the key risks and what to watch next — free, no card.
AI-generated from Quantic's dividend data · Updated 16 Oct 2026 · Information, not financial advice.
Price history
Dividend profile
Yield band A stock's current dividend yield shown against its own range over the past five years — the low, average and high. Near the high end the shares look relatively cheap for the income they pay; near the low end, relatively expensive. It's the picture behind Dividend Yield Theory. Learn more → (5-year)
Payment calendar
Dividend history
Per-share dividend by year
Debt & leverage
Latest reported balance-sheet figures.
Appears in these lists
EL.PA qualifies for these curated dividend rankings.
New to dividend investing?
Information, not financial advice.
Quantic · Free
Track EL.PA and your whole portfolio
Real yield, dividend safety, net-of-tax income and your path to freedom — free, no broker connection.
Need more? Pro adds portfolios, options income tracking & more AI. See Pro →